About LenioBio
LenioBio is a company based in Dusseldorf (Germany) founded in 2016 by Remberto Martis and Hakon Birgisson. LenioBio has raised $13.01 million across 7 funding rounds from investors including EIT Food, European Union and Eureka Network. The company has 18 employees as of December 31, 2020. LenioBio offers products and services including ALiCE® Products, ALiCE® as a Service, and ALiCE® for High-Throughput Expression. LenioBio operates in a competitive market with competitors including PrognomiQ, PreOmics, Vivostat, ACRO Biosystems and List Biological Laboratories, among others.
- Headquarter Dusseldorf, Germany
- Employees 18 as on 31 Dec, 2020
- Founders Remberto Martis, Hakon Birgisson
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Leniobio Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.01 M (USD)
in 7 rounds
-
Latest Funding Round
$4.33 M (USD), Grant
Jul 23, 2025
-
Investors
EIT Food
& 5 more
-
Employee Count
18
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LenioBio
LenioBio offers a comprehensive portfolio of products and services, including ALiCE® Products, ALiCE® as a Service, and ALiCE® for High-Throughput Expression.
Enables rapid and scalable protein production for research.
Offers expert services for challenging protein targets.
Facilitates efficient protein expression in high-throughput setups.
People of LenioBio
Unlock access to complete
Funding Insights of LenioBio
LenioBio has successfully raised a total of $13.01M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $4.33 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in LenioBio
LenioBio has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include EIT Food, European Union and Eureka Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Early-stage tech companies are invested in by Bridford Group.
|
Locked | Locked | Locked | |
|
Food safety testing services are provided by EIT Food.
|
Locked | Locked | Locked |
Investor details for LenioBio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by LenioBio
Investment portfolio details for LenioBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - LenioBio
Detailed financials for LenioBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Leniobio Comparisons
Peer comparison for LenioBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of LenioBio
LenioBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PrognomiQ, PreOmics, Vivostat, ACRO Biosystems and List Biological Laboratories, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of tests for the detection and treatment of cancer and other diseases
|
|
| Locked | Locked | Locked |
Reagents and instruments for proteomics research are supplied by PreOmics.
|
|
| Locked | Locked | Locked |
On-site fibrin sealant preparation systems are developed and provided.
|
|
| Locked | Locked | Locked |
Recombinant proteins are manufactured to support cancer immunotherapy efforts.
|
|
| Locked | Locked | Locked |
Specializes in the production of research reagents
|
Detailed competitors of LenioBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Leniobio
Complete news archive for LenioBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about LenioBio
LenioBio was founded in 2016 and raised its 1st funding round 3 years after it was founded.
LenioBio is headquartered in Dusseldorf, Germany. It is registered at Dusseldorf, North Rhine-westphalia, Germany.
Remberto Martis is the current CEO of LenioBio. They have also founded this company.
LenioBio is a funded company, having raised a total of $13.01M across 7 funding rounds to date.
As of Dec 31, 2020, the latest employee count at LenioBio is 18.
LenioBio was founded in 2016 in Dusseldorf, Germany, and operates in the biotechnology sector. Cell-free protein expression kits are developed and supplied, with the ALiCE platform serving as the primary eukaryotic system for handling difficult-to-express proteins. Active energy regeneration is incorporated, along with essential components for protein folding, disulfide bonding, and glycosylation, supporting discovery, development, and production processes.
LenioBio offers ALiCE® Products, ALiCE® as a Service, and ALiCE® for High-Throughput Expression.
LenioBio has 6 investors. Key investors include EIT Food, European Union, Eureka Network, EIC Fund, and Bridford Group.